(Q37180213)

18 August 2017

1 reference

title

Asthma therapies revisited: what have we learned? (English)

1 reference

18 August 2017

0 references

1

Robert F Lemanske

1 reference

18 August 2017

1 May 2009

1 reference

Proceedings of the American Thoracic Society

18 August 2017

1 reference

18 August 2017

6

1 reference

18 August 2017

3

1 reference

18 August 2017

312-315

1 reference

Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Targeting TNF-alpha: a novel therapeutic approach for asthma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Innate immunity in the pathogenesis of virus-induced asthma exacerbations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

6 September 2017

Omalizumab for asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Regular inhaled beta-agonist treatment in bronchial asthma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Evidence of a role of tumor necrosis factor alpha in refractory asthma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Rhinovirus illnesses during infancy predict subsequent childhood wheezing

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Daily versus as-needed corticosteroids for mild persistent asthma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Persistent wheezing in very young children is associated with lower respiratory inflammation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677407

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

3 September 2018

1 reference

12 December 2020

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial

1 reference

12 December 2020

Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers

1 reference

12 December 2020

Expert Panel Report 3: Moving forward to improve asthma care

1 reference

12 December 2020

The Demise of Anti–IL-5 for Asthma, or Not

1 reference

12 December 2020

A clinical index to define risk of asthma in young children with recurrent wheezing

1 reference

12 December 2020

The Tucson Children's Respiratory Study. II. Lower respiratory tract illness in the first year of life

1 reference

12 December 2020

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

12 December 2020

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

12 December 2020

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

1 reference

12 December 2020

Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction

1 reference

12 December 2020

Inhibition of tumor necrosis factor alpha for refractory asthma

1 reference

12 December 2020

Long-term inhaled corticosteroids in preschool children at high risk for asthma

1 reference

12 December 2020

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma

1 reference

12 December 2020

10.1513/PATS.200806-055RM

Identifiers

DOI

1 reference

18 August 2017

1 reference

PMC publication ID

2677407

18 August 2017

PubMed publication ID

19387036

1 reference

PMC publication ID

2677407